Position in LH
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$627,480
+$40,765 QoQ
Shares Held
2,241
+1.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#538
of 1,040 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 20%
Shared 0%
None 80%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Aptus Capital Advisors, LLC holds $37,453,222 across 9 Diagnostics & Research names. LH ranks #5 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
47,091 | $23,609,543 | |
| 2 | DHR |
Danaher Corp /De/
|
29,809 | $5,678,018 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
9,994 | $5,261,241 | |
| 4 | WAT |
Waters Corp /De/
|
2,003 | $751,205 | |
| 5 | LH |
Labcorp Holdings Inc.
This page
|
2,241 | $627,480 | |
| 6 | ILMN |
Illumina, Inc.
|
3,006 | $528,544 | |
| 7 | NTRA |
Natera, Inc.
|
1,562 | $424,004 | |
| 8 | A |
Agilent Technologies, Inc.
|
2,638 | $350,405 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $627,480 | 2,241 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $586,715 | 2,199 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $547,671 | 2,183 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $583,880 | 2,034 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $639,998 | 2,438 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $465,014 | 1,998 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $454,282 | 1,981 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $428,858 | 1,919 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $392,163 | 1,927 | Shares | Sole | 2024-07-31 | |
| No filing history on record for this holder in this stock. | ||||||